Lately headlines involving pharmaceuticals have become more commonplace — a few recent stories from the OPEN MINDS Weekly News Wire reminded me of the many new developments in this area. Most recently, these developments focused on the opioid crisis (see FDA Approves Six-Month Implant For Opioid Addiction Treatment), new research incubators (see Janssen Launches New Research Platforms For Disease Prevention . . .
Restricted Content

You must be a member to view this resource.

Log in | Sign up or learn more about membership options

Tagged As:

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!